These downstream effectors can mediate insulin resistance directly by downregulating GLUT4 and insulin receptor expression, promoting serine phosphorylation of insulin receptor substrate (IRS-1), or indirectly by inducing inflammatory factors and ROS51. This evidence concerns the gene SLC2A4 and Insulin resistance.